Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron rises on U.S. FDA nod for drug

** Shares of Immuron Ltd  IMC.AX  rise as much as 30.6% to
A$0.094, their highest level since Aug. 31
    ** Biopharmaceutical co receives U.S. Food and Drug
Administration approval for Travelan Investigational New Drug
application (IND)
    ** Says IND was submitted to evaluate the efficacy of single
dose of Travelan to prevent infectious diarrhea caused by
Enterotoxigenic E. coli bacteria 
    ** Co's set for best day since Dec. 1, if gains hold 
    ** About 2.27 mln shares trade hands compared to 30-day
average trading volume of 99,700 shares
    ** Shares of co are down 28% YTD as of last close
 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))

Recent news on Immuron

See all news